CJC-1295 with IPA

Price range: R800,00 through R1 200,00

CJC-1295 + Ipamorelin

What it is: A combination of CJC-1295, a long-acting growth-hormone-releasing hormone (GHRH) analogue, and ipamorelin, a growth-hormone-releasing peptide (GHRP). Together, they are intended to stimulate the body’s own growth-hormone secretion.
Commonly marketed for: Increased growth hormone (GH) and IGF-1 levels, muscle recovery, improved body composition, sleep, and potentially fat loss.
How it’s purported to work: CJC-1295 stimulates the pituitary through the GHRH pathway, while ipamorelin stimulates GH release through the ghrelin/GHS receptor pathway. The two mechanisms are therefore intended to complement one another.
Evidence: CJC-1295 has demonstrated sustained increases in GH and IGF-1 in small human studies, but evidence for meaningful improvements in muscle mass, fat loss, recovery, or other performance outcomes is limited. Evidence specifically supporting the CJC-1295 + ipamorelin combination is also limited.
Key risks/side effects: Increasing GH/IGF-1 can potentially contribute to fluid retention, glucose intolerance, and other GH-related effects. FDA has also identified safety concerns surrounding compounded CJC-1295, including immunogenicity and reported systemic reactions. For ipamorelin, FDA notes limited safety information for subcutaneous administration and concerns regarding peptide impurities/immunogenicity.
Regulatory status: Neither CJC-1295 nor ipamorelin is an FDA-approved treatment for growth-hormone deficiency. FDA materials note that clinical evidence for CJC-1295 has largely involved healthy adults rather than patients with confirmed GH deficiency.
Bottom line: CJC-1295 + ipamorelin is an experimental GH-secretagogue combination with evidence that CJC-1295 can raise GH/IGF-1 levels, but there is insufficient clinical evidence to establish that the combination provides the broader recovery, muscle-building, or fat-loss benefits commonly marketed.

Description

CJC-1295 + IPAMORELIN – ADVANCED GROWTH HORMONE SUPPORT COMPLEX

Elevate Wellness Hub’s CJC-1295 + Ipamorelin peptide complex combines two investigational peptides that act through complementary growth-hormone pathways. The combination is being explored for its potential role in growth-hormone signalling, body composition, recovery, and healthy aging.

KEY BENEFITS

Supports research into natural growth-hormone signalling
Investigated for muscle and lean-body-mass pathways
Supports research into recovery and tissue repair
Investigated for body-composition and metabolic pathways
Supports research into sleep and physiological recovery
Being studied in the context of healthy aging

WHO MAY BENEFIT?

Individuals interested in research into growth-hormone signalling, Those exploring peptide-based recovery research, Individuals studying muscle and body-composition pathways, People interested in research surrounding physiological recovery and healthy aging.

Always use under the guidance of a qualified healthcare professional.

HOW IT MAY HELP

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) and has been investigated for its ability to stimulate growth-hormone secretion
Ipamorelin is a growth-hormone secretagogue that acts through the ghrelin receptor pathway
The two compounds affect complementary pathways involved in growth-hormone signalling
Research has explored their potential relationship with IGF-1, body composition, recovery, and metabolic processes
The combination is commonly investigated as a means of influencing endogenous growth-hormone pathways

The clinical evidence supporting CJC-1295 + Ipamorelin as a combined treatment for wellness, anti-aging, muscle growth, or recovery remains limited.

POSSIBLE SIDE EFFECTS

Potential adverse effects may include:

Headache
Dizziness
Nausea
Fatigue
Injection-site reactions
Fluid retention or swelling
Changes in blood-glucose regulation
Increased appetite
Tingling or numbness

Because these peptides influence growth-hormone signalling, inappropriate use may potentially affect glucose metabolism, fluid balance, and other hormone-related processes.

NOT SUITABLE FOR

Pregnancy or breastfeeding
Anyone with a known allergy or sensitivity to either peptide or any ingredient
Children unless specifically prescribed and supervised by a paediatric endocrinology specialist
Individuals with active or suspected cancer without specialist medical assessment
Individuals with uncontrolled diabetes or significant metabolic disorders without appropriate medical supervision
Anyone with significant endocrine or pituitary disorders without specialist assessment
Anyone using other growth-hormone– or hormone-affecting medicines without professional medical guidance

IMPORTANT DISCLAIMER

CJC-1295 + Ipamorelin is an investigational peptide combination and should not be represented as an approved anti-aging, muscle-building, fat-loss, or recovery treatment.

The individual peptides act on growth-hormone pathways, but the safety and effectiveness of the combination for general wellness purposes have not been established through adequate large-scale clinical trials. FDA has also identified limited safety information and potential concerns regarding compounded CJC-1295 and ipamorelin products.

Elevate Wellness Hub does not represent this product as a substitute for approved medical therapy. Any use must comply with applicable laws and regulations and should only occur under appropriate qualified healthcare-professional supervision or within an authorised research setting.

The 10 mg listed by Elevate Wellness Hub refers to the product strength and is not a dosing recommendation.

It’s not just about feeling better, it’s about elevating your quality of life.

ELEVATE WELLNESS HUB – PEPTIDE WELLNESS – SCIENCE BACKED. RESULTS DRIVEN. YOU ELEVATED.

Additional information

Weight	N/A
Type	VIAL, PEN

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with IPA”